2 unchanged sentences
July 10, 2019, Bosti Trading Ltd., a former distributor in Russia (“Bosti”), filed suit with the Tel Aviv-Jaffa District
−Removed: Court in Israel against InspireMD Ltd., claiming damages for alleged breaches by InspireMD Ltd.
−Removed: under the Distribution Agreement,
−Removed: dated May 26, 2011, between Bosti and InspireMD Ltd., in connection with the voluntary field corrective action of our MGuard Prime
−Removed: EPS we initiated in 2014.
−Removed: Bosti claims that Bosti and its Russian subsidiary returned 1,830 units of MGuard Prime EPS to InspireMD
−Removed: upon initiation of the voluntary filed action, and, since the Russian Ministry of Health prohibited distribution of MGuard
−Removed: Prime EPS on August 28, 2014, and did not approve distribution MGuard Prime EPS until September 20, 2016, Bosti was entitled to
−Removed: recover from InspireMD Ltd.
−Removed: €1,830,000 (which is approximately $2 million), the amount Bosti was due to receive from its
−Removed: Russian subsidiary, or alternatively, €1,024,000 (which is approximately $1.1 million), the amount Bosti paid to InspireMD
−Removed: Ltd., for the MGuard Prime EPS returned to InspireMD Ltd.
+Added: Court in Israel, or the Complaint, against InspireMD Ltd., claiming damages for alleged breaches by InspireMD Ltd.
+Added: under the Distribution
+Added: Agreement, dated May 26, 2011, between Bosti and InspireMD Ltd., in connection with the voluntary field corrective action of our
+Added: MGuard Prime EPS we initiated in 2014.
+Added: Bosti claimed that Bosti and its Russian subsidiary returned 1,830 units of MGuard Prime
+Added: EPS to InspireMD Ltd.
+Added: upon initiation of the voluntary filed action, and, since the Russian Ministry of Health prohibited distribution
+Added: of MGuard Prime EPS on August 28, 2014, and did not approve distribution MGuard Prime EPS until September 20, 2016, Bosti was
+Added: entitled to recover from InspireMD Ltd.
+Added: €1,830,000 (which is approximately $2 million), the amount Bosti was due to receive
+Added: from its Russian subsidiary, or alternatively, €1,024,000 (which is approximately $1.1 million), the amount Bosti paid to
+Added: InspireMD Ltd., for the MGuard Prime EPS returned to InspireMD Ltd.
On January 31, 2020, InspireMD Ltd.
−Removed: filed with court its letter of defense
−Removed: in which it contested this matter vigorously.
−Removed: Due to the uncertainties of litigation, however, we can give no assurance that InspireMD
−Removed: will prevail on any claims made against InspireMD Ltd.
−Removed: in any such lawsuit.
−Removed: Also, we can give no assurance that any other
−Removed: lawsuits or claims brought in the future will not have an adverse effect on our financial condition, liquidity or operating results.
+Added: filed with court its letter
+Added: of defense in which it contested this matter vigorously.
+Added: On January 21, 2021, we executed a Mediation Agreement with Bosti and
+Added: InspireMD Ltd., pursuant to which Bosti agreed to release the Company from all claims stated in the Complaint in exchange for
+Added: a payment of $580,000, which we paid on January 25, 2021.
of the date of this filing, we are not aware of any other material legal proceedings to which we or any of our subsidiaries is
a party or to which any of our property is subject, nor are we aware of any such threatened or pending litigation or any such
−Removed: proceedings known to be contemplated by governmental authorities other than other than the foregoing suit filed by Bosti.
+Added: proceedings known to be contemplated by governmental authorities.
are not aware of any material proceedings in which any of our directors, officers or affiliates or any registered or beneficial
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.